Search results
Cathie Wood's ARK sells Robinhood, buys UiPath and Amgen stock By Investing.com
Investing.com· 5 days agoCathie Wood's ARK sells Robinhood, buys UiPath and Amgen stock
Cathie Wood-Led Ark Invest Sells Nearly $28M Worth Of Robinhood Shares Amid Crypto API Launch And...
Benzinga· 5 days agoOn Thursday, Cathie Wood-led Ark Invest made notable adjustments to its portfolio, including a...
Cathie Wood Is Buying the Dip on These 2 Biotech Stocks. Should You? | The Motley Fool
The Motley Fool· 19 hours agoVia her ARK Innovation ETF (ARKK 0.58%), portfolio manager Cathie Wood makes a lot of biotech bets,...
Intellia ups the ante in HAE dosing battle, showcasing durability of one-and-done option
FierceBiotech· 3 days agoThe future of hereditary angiodema treatment seems to be coming down to how many shots it takes to...
Iridium secures $94 million Space Force contract By Investing.com
Investing.com· 14 hours agoIridium secures $94 million Space Force contract
Evercore ISI cuts Editas Medicine stock target By Investing.com
Investing.com· 6 days agoThe firm's analyst has reduced the price target for the company's shares to $7.00 from the previous...
Cathie Wood's ARK ETFs shuffle biotech, sells Zoom and Exact Sciences stock By Investing.com
Investing.com· 1 day agoCathie Wood's ARK ETFs shuffle biotech, sells Zoom and Exact Sciences stock
Cathie Wood's ARK buys PagerDuty, CRISPR, sells Zoom stock By Investing.com
Investing.com· 4 days agoCathie Wood's ARK buys PagerDuty, CRISPR, sells Zoom stock
Here's How Cathie Wood (Almost) Completely Missed the Boat on Artificial Intelligence (AI) -- and...
The Motley Fool via AOL· 3 days ago...Pharmaceuticals 5 UiPath Block UiPath Iridium Communications Moderna 6 CRISPR Therapeutics Roblox...
Five things: Sam Adams acquisition, Steward hearing, historic parks and the most misunderstood album...
The Business Journals· 2 days agoSteward Health Care is scheduled to appear in U.S. Bankruptcy Court today for the final so-called "first-day motions" hearing. Hannah Green reports on Intellia Therapeutics ...